Phase 3 Smoker Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Completed
Phase 3
Microarray analysis following Anti-Inflammatory Interventions in Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary DiseaseEx-smokers with obstructive airway disease
Hunter New England Health Service15 enrolled1 locationACTRN12611000165987
Completed
Phase 3
Opportunistic referral of smokers to telephone cessation advice from a nurse: a randomised trial in Australian general practice
Smokers
Dr Jane Young318 enrolled1 locationACTRN12607000091404
Recruiting
Phase 3
NicoNovum Evaluation of Withdrawal Relief Study Part 2
Smokers
Professor Peter Hajek52 enrolled1 locationACTRN12607000086460